辉瑞CEO Albert Bourla 表示认同 Anthropic CEO Dario Amodei 对 AI 加速医学进步的乐观判断,并称辉瑞从药物发现到生产已见成效。但他强调,识别有前景的分子只是开始,药物安全有效必须经患者中严谨试验验证,需经验丰富的研究者和医生参与。他认为 AI 的速度与科学纪律结合,患者将比许多人预期更早受益。
Share Dario’s optimism. AI is changing the pace of medical progress, and in our industry time is life. Already seeing this across @Pfizer from discovery to manufacturing.
But as a scientist I also know how humbling biology can be. Identifying a promising molecule is just the beginning. The only way to know if a medicine is safe and effective is careful, rigorous testing in patients. That takes time, and needs experienced researchers and physicians in the loop.
The future I see is AI’s speed and scientific discipline working together. If we get that right, patients will benefit sooner than many expect.
Anthropic CEO Dario Amodei thinks cancer, Alzheimer’s, heart disease, and mental illness will be “relics of the past” in less than a decade, thanks to AI.在 X 查看被引用的帖子
来源:Albert Bourla · x.com